• 제목/요약/키워드: CA therapy

검색결과 247건 처리시간 0.026초

The Leaves of Broussonetia kazinoki Siebold Inhibit Atopic Dermatitis-Like Response on Mite Allergen-Treated Nc/Nga Mice

  • Lee, Hoyoung;Ha, Hyekyung;Lee, Jun Kyoung;Park, Sang-Joon;Jeong, Seung-Il;Shin, Hyeun Kyoo
    • Biomolecules & Therapeutics
    • /
    • 제22권5호
    • /
    • pp.438-444
    • /
    • 2014
  • Broussonetia kazinoki Siebold. (B. kazinoki) has long been used in the manufacture of paper in Asian countries. Although B. kazinoki leaves (BK) have been employed in dermatological therapy, use of BK has not been tested in patients with atopic dermatitis (AD). Using Nc/Nga mice, which are genetically predisposed to develop AD-like skin lesions, we confirmed the efficacy of BK in AD treatment. BK extract was applied topically to Dermatophagoides farinae-induced AD-like lesions in Nc/Nga mice, and the effects were assessed both clinically and by measuring skin thickness on the back and ears. We measured the effects of BK extract on plasma levels of IgE and IL-4. We also measured the ability of BK extract to inhibit the secretion of hTARC in HaCaT cells after stimulation by TNF-${\alpha}$ and IFN-${\gamma}$. We found that BK extract significantly reduced ear and dorsal skin thickness and the clinical signs of AD, as well as significantly down-regulating the plasma levels of IgE and IL-4 (p<0.01 for each comparison). Moreover, $500{\mu}g/mL$ of BK extract inhibited hTARC secretion in HaCaT cells by activated TNF-${\alpha}$/IFN-${\gamma}$ by about 87%. These findings suggest that topical application of BK extract has excellent potential in the treatment of AD.

Phosphatidylinositol 3-kinase (PI3KCA) Oncogene Mutation Analysis and Gene Expression Profiling in Primary Breast Cancer Patients

  • Kandula, Mahesh;Chennaboina, Kalyan Kumar;Ammi Raju, Y.S.;Raju, Suryanarayana
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권9호
    • /
    • pp.5067-5072
    • /
    • 2013
  • Background: The phosphatidylinositol 3-kinase (PI3K) pathway plays a significant role in apoptosis, cellular proliferation and motility. The aim of the present study was to analyze mutations and gene expression profiles of the PI3KCA gene to determine any role in breast carcinomas. Materials and Methods: We analyzed 38 breast cancers for mutations in the two PIK3CA hotspots in exons 9 and 20 by direct sequencing of DNA obtained from biopsy samples. We have also analyzed expression of the PI3KCA gene in 38 breast carcinoma tumor and corresponding control tissue samples at the mRNA level by RT-PCR. The Fisher's exact test ($2{\times}2$ only) was performed using MedCalc software for to examine associations with mRNA levels. Results: In the present study a total of 13 cases demonstrated somatic mutations. In 9/13 cases 1633 G>A (E545K) were found in exon 9, whereas in exon 20, 4/13 cases had 3140A>G mutation. Our combined analysis showed PI3KCA mutations present in 34% of human breast cancer patients. In our study, we have also clearly found significantly higher expression in breast cancer tissues in comparison with control tissues (p=0.001). Conclusions: PIK3CA mutation is an emerging tumor marker that, in the future, might be used in the process of choosing a treatment. The detection of PI3KCA mutation might have important clinical implications for diagnosis, progression and therapy.

Safety and Efficacy of Flow Diverter Therapy for Unruptured Intracranial Aneurysm Compared to Traditional Endovascular Strategy : A Multi-Center, Randomized, Open-Label Trial

  • Kim, Junhyung;Hwang, Gyojun;Kim, Bum-Tae;Park, Sukh Que;Oh, Jae Sang;Ban, Seung Pil;Kwon, O-Ki;Chung, Joonho;Committee of Multicenter Research, Korean Neuroendovascular Society,
    • Journal of Korean Neurosurgical Society
    • /
    • 제65권6호
    • /
    • pp.772-778
    • /
    • 2022
  • Objective : Endovascular treatment of large, wide-necked intracranial aneurysms by coil embolization is often complicated by low rates of complete occlusion and high rates of recurrence. A flow diverter device has been shown to be safe and effective for the treatment of not only large and giant unruptured aneurysms, but small and medium aneurysms. However, in Korea, its use has only recently been approved for aneurysms <10 mm. This study aims to compare the safety and efficacy of flow diversion and coil embolization for the treatment of unruptured aneurysms ≥7 mm. Methods : The participants will include patients aged between 19 and 75 years to be treated for unruptured cerebral aneurysms ≥7 mm for the first time or for recurrent aneurysms after initial endovascular coil embolization. Participants assigned to a flow diversion cohort will be treated using any of the following devices : Pipeline Flex Embolization Device with Shield Technology (Medtronic, Minneapolis, MN, USA), Surpass Evolve (Stryker Neurovascular, Fremont, CA, USA), and FRED or FRED Jr. (MicroVention, Tustin, CA, USA). Participants assigned to a coil embolization cohort will undergo traditional endovascular coiling. The primary endpoint will be complete occlusion confirmed by cerebral angiography at 12 months after treatment. Secondary safety outcomes will evaluate periprocedural and post-procedural complications for up to 12 months. Results : The trial will begin enrollment in 2022, and clinical data will be available after enrollment and follow-up. Conclusion : This article describes the aim and design of a multi-center, randomized, open-label trial to compare the safety and efficacy of flow diversion versus traditional endovascular treatment for unruptured cerebral aneurysms ≥7 mm.

MethA Fibrosarcoma Cells Expressing Membrane-Bound Forms of IL-2 Enhance Antitumor Immunity

  • Sonn, Chung-Hee;Yoon, Hee-Ryung;Seong, In-Ock;Chang, Mi-Ra;Kim, Yong-Chan;Kang, Han-Chul;Suh, Seok-Cheol;Kim, Young-Sang
    • Journal of Microbiology and Biotechnology
    • /
    • 제16권12호
    • /
    • pp.1919-1927
    • /
    • 2006
  • Tumor cells genetically engineered to secrete cytokines are effective in tumor therapy, but various unexpected side effects are observed, which may result from the bulk activation of various bystander cells. In this study, we tested tumor vaccines expressing various membrane-bound forms of IL-2 (mbIL-2) on MethA fibrosarcoma cells to focus antitumor immune responses to CTL. Chimeric forms of IL-2 with whole CD4, deletion forms of CD4, and TNF were expressed on the tumor cell surface, respectively. Tumor clones expressing mbIL-2 or secretory form of IL-2 were able to support the cell growth of CTLL-2, an IL-2-dependent T cell line, and the proliferation of spleen cells from 2C TCR transgenic mice that are responsive to the $p2Ca/L^d$ MHC class I complex. Expression of mbIL-2 on tumor cells reduced the tumorigenicity of tumor cells, and the mice that once rejected the live IL-2/TNF tumor clone acquired systemic immunity against wild-type MethA cells. The IL-2/TNF clone was inferior to other clones in tumor formation, and superior in the stimulation of the CD8+ T cell population in vitro. These results suggest that the IL-2/TNF clone is the best tumor vaccine, and may stimulate CD8+ T cells by direct priming. Expression of IL-2/TNF on tumor cells may serve as an effective gene therapy method to ameliorate the side effects encountered in the recombinant cytokine therapy and the conventional cytokine gene therapy using the secretory form of IL-2.

불안정 발판(Unstable Platform)에서 20대 연령의 균형능력 평가 (Evaluation of the Balance Ability for 20 to 29 Years Old on the Unstable Platform)

  • 권오윤;최홍식
    • 한국전문물리치료학회지
    • /
    • 제3권3호
    • /
    • pp.1-11
    • /
    • 1996
  • The purpose of this study were to evaluate and compare the balance ability at different conditions in normal 20 to 29 years old on unstable platform, KAT 2000(Breg, Inc., Vista, CA. 1994). Static and dynamic BI(balance index) were measured 3psi and 5psi surface conditions. Static tests were done on right and left leg separately, then both legs together with the feet apart 20cm with the eyes opened and closed. Dynamic tests were done on both legs together with apart 20cm with the eyes opened. A dynamic test was performed in which the subject moved platform in a circular manner to chase a moving object on a computer screen. Seventy healthy students(average 21.6 years, male, female) were tested. In this study applied the paired t-test and correlation to determine the statistical significance of result. The results were as follow: 1) The mean static balance index of the Rt leg was $119.9{\pm}75.72$ on 3psi surface condition with the eyes opened, and that of the Lt leg was $224.3{\pm}121.16$. 2) The mean static balance index of the Rt leg was $93.1{\pm}24.16$ on 5psi surface condition with the eyes opened, and that of the Lt leg was $180.5{\pm}61.76$. 3) The mean static and dynamic balance index of both legs were $76.4{\pm}31.86$, $2187.6{\pm}696.99$ on 3psi with the eyes opened, and $68.3{\pm}14.82$, $1938.7{\pm}525.41$ on 5psi respectively. 4) The mean static balance index of the Rt leg was $517.8{\pm}220.87$ on 3psi surface condition with the eyes closed, and that of the Lt leg was $588.6{\pm}204.81$. 5) The mean static balance index of the Rt leg was $271.9{\pm}192.151$ on 5psi surface condition with the eyes closed, and that of the Lt leg was $363.4{\pm}98.97$. 6) The mean static balance index of both legs was $332.6{\pm}137.31$ on 3psi surface condition with the eyes closed, and that of the 5psi was $288.5{\pm}133.07$. 7) The balance index on 3psi surface condition was significantly higher than that of 5psi (p<0.05, p<0.01). 8) The balance index with the eyes closed was significantly higher than that of the eyes opened (p<0.05). 9) The balance index on the left leg was significantly higher than that of the right leg (p<0.05, p<0.01). 10) There was no correlation between static balance index and dynamic balance index. 11) Therewas no correlation between weight or height and balance index.

  • PDF

뇌졸중 후 인지장애의 침 치료에 대한 임상적 연구 고찰 (A Study of Clinical Research Acupuncture Treatment on Post-stroke Cognitive Disorder)

  • 김삼룡;윤종민;문병순
    • 대한한방내과학회지
    • /
    • 제39권3호
    • /
    • pp.389-404
    • /
    • 2018
  • Objective: The aim of this study was to investigate acupuncture therapy for post-stroke cognitive disorder to suggest the methods of a study about acupuncture therapy. Methods: Several academic databases were used in this study, including National Digital Science Library (NDSL), National Assembly Library of Korea, Korean Traditional Knowledge Portal, Research Information Sharing Service (RISS), Korean studies Information Service System (KISS), Korean Medical Database (KMBASE), Korea Med, Oriental Medicine Advanced Searching Integrated System (OASIS), PubMed, MEDLINE with Full Text, and China National Knowledge Infrastructure (CNKI). Keywords used were "중풍", "뇌졸중", "인지장애", "침", "acupuncture", and "cognitive disorder". Results: Ultimately, 28 papers were investigated. that were mainly published in 2012 and 2016. Of these, More than two-thirds received a score of one or less on the Jadad scale. Acupuncture points such as GV20, GV24, PC6, EX-HN1, SP6, and GV26 were most frequently used. The treatment duration was mostly 30 minutes or less, and the treatment cycle was mostly for four weeks. Dilatational wave was generally used in pulse wave form, and amplitude of electricity was increased until patients were able to endure. G6805 was generally used in electric acupuncture apparatus. According to results of acupuncture treatment, assessments such as the MMSE (Mini Mental State Examination) and the Montreal Cognitive Function Assessment Scale (MoCA) showed statistically significant improvements in 28 studies. Conclusions: Future research is needed to standardize the treatment of acupuncture, and more diversified high quality papers should be published to help clarify the therapeutic effects of acupuncture and the mechanisms of cognitive disorder post-stroke.

A comparative evaluation of $CO_2$ and erbium-doped yttrium aluminium garnet laser therapy in the management of dentin hypersensitivity and assessment of mineral content

  • Belal, Mahmoud Helmy;Yassin, Abdulaziz
    • Journal of Periodontal and Implant Science
    • /
    • 제44권5호
    • /
    • pp.227-234
    • /
    • 2014
  • Purpose: Dentin hypersensitivity is a potential threat to oral health. Laser irradiation may provide reliable and reproducible treatment but remains controversial. The present study aimed to evaluate the effects of $CO_2$ or erbium-doped yttrium aluminium garnet (Er:YAG) laser therapy, and to assess mineral content. Methods: Eighteen human single-rooted teeth affected with advanced periodontitis were obtained. Buccal and lingual surfaces were planed to form 36 specimens. Ethylenediaminetetraacetic acid gel (24%) was applied to remove the smear layer and simulate hypersensitive teeth. The experimental groups were: group 1, control (no irradiation); group 2, $CO_2$ laser (repetitive pulsed mode, 2 W, $2.7J/cm^2$); and group 3, Er:YAG laser (slight contact mode, 40 mJ/pulse and 10 Hz). To evaluate dentinal tubule occlusion, six specimens per group (2-mm thickness) were prepared and observed using scanning electron microscopy (SEM) for calculation of the occlusion percentage. To evaluate the mineral content, six specimens per group (0.6-mm thickness) were used, and then the levels of Ca, K, Mg, Na, and P were measured by inductively coupled plasma-atomic emission spectrometry. In addition, the surface temperature of the specimens during laser irradiation was analyzed by a thermograph. Results: The SEM photomicrographs indicated melted areas around exposed dentinal tubules and a significantly greater percentage of tubular occlusion in the $CO_2$ and Er:YAG laser groups than the control, and in the Er:YAG group than the $CO_2$ laser group. In addition, no significant differences were noted among the experimental groups for the mineral elements analyzed. The $CO_2$ laser group showed an evident thermal effect compared to the Er:YAG group. Conclusions: $CO_2$ and Er:YAG laser are effective in treating dentin hypersensitivity and reducing its symptoms. However, the Er:YAG laser has a more significant effect; thus, it may constitute a useful conditioning item. Furthermore, neither $CO_2$ nor Er:YAG lasers affected the compositional structure of the mineral content.

구취와 타액내의 미생물 수에 대한 비외과적 치주치료의 영향 (Impact of nonsurgical periodontal therapy on oral malodor and microbial load of saliva)

  • 김명진;김성조;최점일;이주연
    • Journal of Periodontal and Implant Science
    • /
    • 제37권1호
    • /
    • pp.1-10
    • /
    • 2007
  • 연구 목적 : 구취의 주된 화학적 요소는 휘발성 황 화합물 (VSCs)들이다. 이들은 치태, 설태, 타액과 혈액, 상피세포의 혐기성 그람 음성 세균에 의한 단백분해 변성으로 만들어 진다. 또한 구취는 치주질환과 타액내의 세균의 증가를 야기하는 불량한 구강 위생상태에서 기인한다고 보고되고 있다. 이 연구의 목적은 VSCs를 측정함으로 구취에 대한 비외과적 치주 치료의 영향을 평가하고, 타액내의 세균 수를 측정함으로써 VSCs와의 상관관계를 살펴보고자 하는 것이다. 연구 대상 및 방법 : 중등도의 만성치주염을 가지는 23명의 참가자들이 대조군과 실험군으로 분류되었다. 대조군은 구강위생교육 (치간청결기구와 혀세정 포함)만을 시행하였고 실험군은 구강위생교육과 함께 24시간 내에 전악 치석제거술과 치근활택술을 시행하였다. 치료 전과 치료 4주 후에 VSCs 농도를 $Halimeter^{(R)}$(Interscan Corp., CA, USA)를 사용하여 측정하였고 타액 시료는 혐기성과 호기성 조건에서 배양되었다. 결과 : 4주 후에 두 군 모두에서 휘발성 황화합물의 농도가 유의하게 감소하였고, 실험군에서의 감소량이 통계적으로 유의하게 더 크게 나타났다. 타액 내 세균의 배양에서 총세균수에 대한 혐기성 세균의 비율이 실험군에서만 통계적으로 유의하게 감소하였다. 그러나 세균의 비율과 휘발성 황화합물의 농도와의 상관관계는 낮게 나타났다. 즉 구취의 감소는 타액 요인 보다는 치주치료에 의한 다른 복합적인 인자의 작용에 의한 것으로 추론할 수 있었다. 결론 : 본 연구는 중등도의 치주염환자에서 구강위생교육만으로도 구취의 주요 화학적 요인인 휘발성 황화합물의 농도를 감소시킬 수 있으나 비외과적 치주치료를 동반하였을 때 더욱 큰 효과를 얻을 수 있는 것으로 해석된다. 그러나 실험 참가자의 수가 적었고 장기간의 분석이 이루어지지 않았으므로 앞으로 더 많은 연구가 구취에 대한 치주치료의 영향을 이해하기 위해서 필요할 것으로 사료된다.

동적다엽콜리메이터를 이용한 세기변조방사선 치료 시 선량분포상의 선량률 변화에 따른 효과 (Effect of Dose Rate Variation on Dose Distribution in IMRT with a Dynamic Multileaf Collimator)

  • 임경달;제영완;윤일규;이제희;유숙현
    • 대한방사선치료학회지
    • /
    • 제24권1호
    • /
    • pp.1-10
    • /
    • 2012
  • 목 적: 동적다엽콜리메이터를 이용한 세기변조방사선 치료 시 선량률 임의 변경 되었을 경우 선량 분포 차와 변화를 평가하고자 한다. 대상 및 방법: 소조사야와 대조사야의 두 가지 세기변조방사선치료계획을 임상적 치료계획시스템(Eclipse, Varian, Palo Alto, CA)을 이용하여 계획하였다. 각각의 치료계획은 선량률 100, 400, 600 MU/min으로 변화시켜 조사야별 세 종류로 치료계획을 하였다. 측정기 2D-Array (2D-Array Seven729, PTW-Freiburg)는 측정 깊이 0.5 cm를 고려하여 위로 Solid water phantom ($30{\times}30{\times}4.5cm$)와 아래로 후방산란을 고려한 Solid water phantom 5 cm 사이에 위치 시켰다. MLC-120엽을 갖춘 에너지 6 MV 선형가속기(Clinac 21EX, Varian, Palo Alto, CA)를 사용하여 실험하였다. 첫 번째로 선량률 100, 400, 600 MU/min의 치료 계획한 것을 같은 선량률로 측정 하여 각각의 기준값을 얻었다. 1) 선량률 100 MU/min일 때 임의로 200, 300, 400, 500, 600 MU/min로 변화하고, 2) 400 MU/min일 때 100, 200, 300, 500, 600 MU/min으로 변화시켰으며, 3) 600 MU/min일 때 100, 200, 300, 400, 500 MU/min를 측정하였다. 끝으로 분석 프로그램(Verisoft 3.1, PTW-Freiburg)을 이용하여 기준 값과 선량률 변화 시의 선량차와 분포를 평가 하였다. 결 과: 치료 계획한 선량률 100 MU/min, 400 MU/min, 600 MU/min을 치료 계획한 대로 측정한 기준 값은 미세한 선량차를 보였고 선량분포도 일치하였다. 이를 기준 값으로 하여 소조사야에 대해 측정한 결과 100 MU/min에서는 200, 300, 400, 500, 600MU/min으로 변경하며 측정 시 -0.8, -1.1, -1.3, -1.5, -1.6%로 선량차가 있었으며, 400 MU/min (소조사야)에서 100, 200, 300, 500, 600 MU/min일 때 +0.9, +0.3, +0.1, -0.2, -0.2%의 선량변화가 있었고, 선량률 600 MU/min (소조사야)에서는 100, 200, 300, 400, 500 MU/min으로 변경 시 +1.4, +0.8, +0.5, +0.3, +0.2%로 나타났다. 다른 한편, 대조사야에서 100 MU/min(대조사야)는 -1.3, -1.6, -1.8, -2.0, -2.4%로 조금 더 큰 감소를 보였고, 400 MU/min (대조사야)는 +2.0, +1.8, +0.5, -1.2, -1.6%의 선량변화가 있었다. 600 MU/min (대조사야)에서는 +1.5, +1.9, +1.7, +1.9, +1.2%였다. 선량률 변화에 따른 선량 차는 -2.4~+2.0%로 측정되었다. 결 론: 120-MLC를 갖춘 선형가속기를 사용하여 측정한 세기변조방사선 치료 시 선량률 변화에 따른 선량분포는 거의 변화가 없었으며 선량 차는 ${\pm}3%$ 미만이었다.

  • PDF

성조숙증 혹은 조기 사춘기가 있는 여아에서 단기간의 성선자극호르몬 방출호르몬 효능약제 사용이 골밀도에 미치는 영향 (Effect of GnRH analogue on the bone mineral density of precocious or early pubertal girls)

  • 임정숙;한헌석
    • Clinical and Experimental Pediatrics
    • /
    • 제52권12호
    • /
    • pp.1370-1376
    • /
    • 2009
  • 목 적:성선자극호르몬 효능약제로 성조숙증을 치료하는 동안에 성선자극호르몬이 억제되고 성선 스테로이드가 감소되면 사춘기 발달동안의 골량에 좋지 않은 영향을 미칠 수가 있어, 성조숙증 혹은 조기 성성숙이 있는 여아에서 성선자극호르몬 효능약제 단독 혹은 성장호르몬과 같이 사용하여 치료하는 경우에 단기간 동안의 골밀도의 변화가 어떠한지를 알아보고자 하였다. 방 법:성장클리닉을 방문한 여아들 중 특발성 성조숙증 혹은 조기 성성숙을 보이며 역연령에 비하여 골연령이 증가되어 있는 여아 40명(역연령 $9.0{\pm}1.5$세, 골연령 $11.6{\pm}1.3$년)을 대상으로, 26명은 성선자극호르몬 효능약제 단독으로 치료하였고(Group I), 14명은 성장호르몬과 병합요법(Group II)으로 치료하였다. 치료 전후에 골연령과 골밀도를 구하고, 역연령과 골연령에 대한 골밀도를 비교하였다. 결 과:전체 환아에서 치료 전후에 역연령으로 비교한 골밀도는 정상범위에 있었으나, 골연령으로 비교해 보면 정상범위에 비하여 감소되어 있었다(P<0.05). 치료기간 동안의 골밀도의 표준편차점수는 역연령 기준으로는 변화가 없었으나, 골연령 기준으로는 의미 있는 증가를 보였다(P<0.05). 치료 전후에 성선자극호르몬 효능약제 단독 치료군의 골밀도 표준편차점수는 역연령 혹은 골연령 기준으로 변화가 없었으나, 성장호르몬 병합 치료군의 골밀도 표준편차점수는 역연령 기준에는 변화가 없었으나 골연령 기준으로는 의미 있는 증가를 보였다(P<0.05). 결 론:성선자극호르몬 방출호르몬 효능약제를 사용하는 동안 역연령에 따른 골밀도의 저하는 관찰되지 않았으나, 골연령에 따른 골밀도의 저하는 관찰되어, 투약 중단 후 성선 기능이 회복되면 골밀도의 정상화의 가능성에 대한 추적 관찰이 필요하겠다. 한편으로는 성장호르몬을 같이 치료한 경우에는 치료 경과 중 골밀도의 의미 있는 증가를 볼 수 있어 성선자극호르몬 효능약제를 사용할 때 고려해야 할 사항으로 보인다.